Search

everythinglearnresearchcommunity

for

Search:↓

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Some treatments like topical oxygen and stem cells show promise for wound healing and hair growth, but evidence for modern dressings over traditional ones is limited.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

TNF family proteins are crucial for the development of skin features like hair, teeth, and mammary glands.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Lithocholic acid helps hair growth and regeneration in alopecia by activating vitamin D receptors.

A woman with Degos disease managed her condition for nine years with medications and had two healthy pregnancies, while a separate finding suggests a possible link between female pattern hair loss and high blood pressure.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Chemokine signaling is important for hair development.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Ficus carica leaf extract may help treat skin disorders by reducing inflammation and androgen effects in skin cells.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Blocking Prostaglandin D₂ may help treat hair loss.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

The article concludes that understanding the molecular processes in hair follicle development can improve the quality of fibers like Angora and cashmere.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

Stress can stop hair growth in mice, and treatments can reverse this effect.

Stress may affect hair growth by influencing hair follicle development and could contribute to hair loss.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

Hair follicle development is controlled by interactions between skin tissues and specific molecular signals.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.